Treatment Outcomes of Carcinoma of the Breast in Pregnancy in Port Harcourt, Nigeria
DOI:
https://doi.org/10.14738/jbemi.92.11841Keywords:
Breast cancer, Pregnancy, Treatment, Outcome, Port Harcourt, Nigeria.Abstract
Background: The belief that breast cancer during pregnancy is more aggressive than in non-pregnant women is still very common in our environment, even amongst medical personnel. Many clinicians still advise women with breast cancer during pregnancy to terminate the pregnancy on prognostic fears. Diagnosis of breast cancer during pregnancy is often delayed due to delayed presentation and some difficulties encountered with imaging during pregnancy. We present the outcomes of management as studied in this center.
Materials and Methods: Information was collected from pregnant women who presented to the breast clinic over a 5-year period. The same treatment was given to all of them and the outcomes of treatment analyzed.
Results: A total of 31 patients were seen during the period. The patients’ age was between 28years and 39years, with a mean age of 32.5years. Clinical staging showed that 20 patients (64.5%) were Manchester stage II, 9 (29%) stage III, 1 (3.2%) had stage I disease, while only one patient (3.2%) had stage IV disease. Majority of the patients in the study had acceptable outcomes for both the mothers and babies.
Conclusion: Pregnancy does not increase the mortality of breast cancer, as some erroneously believe. Accurate timing of chemotherapy and radiotherapy results in no significant harm to the baby. Termination of a desired pregnancy should not be advised unless the woman so desires.
References
Polivka J, Altun I, Golubnitschaja O. Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine. Epma Journal. 2018;9(1):1-13.
Du Bois A, Meerpohl H, Gerner K, Prömpeler H, Vach W, Aisslinger U, et al. Effect of pregnancy on the incidence and course of malignant diseases. Geburtshilfe und Frauenheilkunde. 1993;53(9):619-24.
Calsteren Kv, Heyns L, Smet FD, Eycken LV, Gziri MM, Gemert WV, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. 2010.
Litton JK, Theriault RL, Gonzalez-Angulo AM. Breast cancer diagnosis during pregnancy. Women’s Health. 2009;5(3):243-9.
Loibl S, Von Minckwitz G, Gwyn K, Ellis P, Blohmer JU, Schlegelberger B, et al. Breast carcinoma during pregnancy: international recommendations from an expert meeting. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2006;106(2):237-46.
Anderson JM. Mammary cancers and pregnancy. Br Med J. 1979;1(6171):1124-7. 84
Chiedozi L, Iweze F, Aboh I, Ajabor L. Breast cancer in pregnancy and lactation. Tropical and geographical medicine. 1988;40(1):26-30.
Clark R, Chua T. Breast cancer and pregnancy: the ultimate challenge. Clinical Oncology. 1989;1(1):11-8.
Nugent P, O'Connell TX. Breast cancer and pregnancy. Archives of Surgery. 1985;120(11):1221-4.
Stensheim H, Møller B, Van Dijk T, Fosså SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. Journal of Clinical Oncology. 2009;27(1):45-51.
Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. The Cancer Journal. 2010;16(1):76-82.
Halaska MJ, Pentheroudakis G, Strnad P, Stankusova H, Chod J, Robova H, et al. Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: A matched controlled study. The breast journal. 2009;15(5):461-7.
Ruiz R, Herrero C, Strasser-Weippl K, Touya D, Louis JS, Bukowski A, et al. Epidemiology and pathophysiology of pregnancy-associated breast cancer: a review. The Breast. 2017;35:136-41.
Sharma R. Breast cancer burden in Africa: evidence from GLOBOCAN 2018. Journal of Public Health. 2021;43(4):763-71.
Hassan I, Muhammed I, Attah M, Mabogunje O. Breast cancer during pregnancy and lactation in Zaria, Nigeria. East African medical journal. 1995;72(5):280-2.
Dusengimana JMV, Hategekimana V, Borg R, Hedt-Gauthier B, Gupta N, Troyan S, et al. Pregnancy-associated breast cancer in rural Rwanda: the experience of the Butaro Cancer Center of Excellence. BMC cancer. 2018;18(1):1-8.
Hou N, Ogundiran T, Ojengbede O, Morhason-Bello I, Zheng Y, Fackenthal J, et al. Risk factors for pregnancyassociated breast cancer: a report from the Nigerian Breast Cancer Study. Annals of epidemiology. 2013;23(9):551-7.
Garba E, Uyanne P, Oguntayo A, Lafia S, Udezue N. Breast cancer in pregnancy: management approach. Nigerian Journal of Surgical Research. 2001;3(3):111-7.
Abur PP, Yusufu LM, Odigie VI. Clinicopathological features, treatment, and outcome of pregnancy-associated breast cancer in Ahmadu Bello University Teaching Hospital, Zaria, Northwestern Nigeria. Archives of Medicine and Surgery. 2019;4(2):46.
Jamabo R, Eke N, John C. Pregnancy-associated breast cancer; a management dilemma in Nigeria. Sahel Medical Journal. 2004;7(2):69-72.
Nsaful J, Vanderpuye V, Scott AA, Dedey F, Oppong SA, Appiah-Danquah R, et al. Experiences and challenges in the management of pregnancy-associated breast cancer at the Korle Bu Teaching Hospital: a review of four cases. ecancermedicalscience. 2020;14.
Eedarapalli P, Jain S. Breast cancer in pregnancy. Journal of obstetrics and gynaecology. 2006;26(1):1-4.
Garcia-Manero M, Royo M, Espinos J, Pina L, Alcazar J, Lopez G. Pregnancy associated breast cancer. European Journal of Surgical Oncology (EJSO). 2009;35(2):215-8.
Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Japanese journal of cancer research. 1992;83(11):1143-9.
Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, et al. Influence of pregnancy on the outcome of breast cancer: A case-control study. International journal of cancer. 1997;72(5):720-7.
Nettleton J, Long J, Kuban D, Wu R, Shaeffer J, El-Mahdi A. Breast cancer during pregnancy: quantifying the risk of treatment delay. Obstetrics & Gynecology. 1996;87(3):414-8.
Navrozoglou I, Vrekoussis T, Kontostolis E, Dousias V, Zervoudis S, Stathopoulos E, et al. Breast cancer during pregnancy: a mini-review. European Journal of Surgical Oncology (EJSO). 2008;34(8):837-43. 85
Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Archives of Surgery. 2003;138(1):91-8.
Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003;98(5):1055-60.
Reed W, Hannisdal E, Skovlund E, Thoresen S, Lilleng P, Nesland J. Pregnancy and breast cancer: a population-based study. Virchows Archiv. 2003;443(1):44-50.
Parente JT, Amsel M, Lerner R, Chinea F. Breast cancer associated with pregnancy. Obstetrics and gynecology. 1988;71(6 Pt 1):861-4.
King R, Welch J, Martin Jr J, Coulam C. Carcinoma of the breast associated with pregnancy. Surgery, gynecology & obstetrics. 1985;160(3):228-32.
Petrek JA. Breast cancer during pregnancy. Cancer. 1994;74(S1):518-27.
Jones AL. Management of pregnancy-associated breast cancer. The breast. 2006;15:S47-S52.
Duncan PG, Pope W, Cohen MM, Greer N. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology. 1986;64(6):790-4.
Keinan-Boker L, Lerner-Geva L, Kaufman B, Meirow D. Pregnancy-associated breast cancer. The Israel Medical Association journal. 2008;10(10):722.
Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107(6):1219-26.
Crawford J, Lewis M. Nitrous oxide in early human pregnancy. Anaesthesia. 1986;41(9):900-5.
Goldhirsch A, Ingle JN, Gelber R, Coates A, Thürlimann B, Senn H-J. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Annals of oncology. 2009;20(8):1319-29.
Leyder M, Laubach M, Breugelmans M, Keymolen K, De Greve J, Foulon W. Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy. Gynecologic and obstetric investigation. 2011;71(2):141-4.
Paskulin GA, Gazzola Zen PR, de Camargo Pinto LL, Rosa R, Graziadio C. Combined chemotherapy and teratogenicity. Birth Defects Research Part A: Clinical and Molecular Teratology. 2005;73(9):634-7.
Doll D. Antineoplastic agents and pregnancy. Semin Oncol. 1989;16:337-46.
Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Archives of Internal Medicine. 1992;152(3):573-6.
Amant F, Van Calsteren K, Halaska MJ, Beijnen J, Lagae L, Hanssens M, et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Rare and Uncommon Gynecological Cancers. 2011:209-27.
Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. The lancet oncology. 2004;5(5):283-91.
Peccatori FA, Azim HA, Scarfone G, Gadducci A, Bonazzi C, Gentilini O, et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast cancer research and treatment. 2009;115(3):591-4.
Ring A, Ellis P. Breast cancer and pregnancy. Breast Cancer and Molecular Medicine. 2006:863-78.
Mir O, Berveiller P, Ropert S, Goffinet F, Pons G, Treluyer J-M, et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Oncology in Clinical Practice. 2008;4(2):65-73.
Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer treatment reviews. 2008;34(4):302-12.
Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. European journal of cancer. 2010;46(18):3158-68. 86
Potluri V, Lewis D, Burton GV. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature. Clinical breast cancer. 2006;7(2):167-70.
Perez EA. Cardiac toxicity of ErbB2-targeted therapies: what do we know? Clinical breast cancer. 2008;8:S114-S20.
Greskovich Jr J, Macklis RM, editors. Radiation therapy in pregnancy: risk calculation and risk minimization. Seminars in oncology; 2000.
Antypas C, Sandilos P, Kouvaris J, Balafouta E, Karinou E, Kollaros N, et al. Fetal dose evaluation during breast cancer radiotherapy. International Journal of Radiation Oncology* Biology* Physics. 1998;40(4):995-9.
Jensen E, Desombre E, Kawashima T, Suzuki T, Kyser K, Jungblut P. Estrogen-binding substances of target tissues. Science. 1967;158(3800):529-30.
McGuire WL. Steroid hormone receptors and disease: breast cancer. Proceedings of the Society for Experimental Biology and Medicine. 1979;162(1):22-5.
Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, et al. The impact of pregnancy on breast cancer outcomes in women≤ 35 years. Cancer. 2009;115(6):1174-84.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Solomon N. Elenwo, Promise N. Wichendu, Rex Friday Ogoronte Alderton Ijah
This work is licensed under a Creative Commons Attribution 4.0 International License.
